Website được thiết kế tối ưu cho thành viên chính thức. Hãy Đăng nhập hoặc Đăng ký để truy cập đầy đủ nội dung và chức năng. Nội dung bạn cần không thấy trên website, có thể do bạn chưa đăng nhập. Nếu là thành viên của website, bạn cũng có thể yêu cầu trong nhóm Zalo "NCKH Members" các nội dung bạn quan tâm.

ứng dụng phần mềm GPA (Glaucoma Progression Analysis) trong đánh giá tiến triển bệnh glôcôm

nckh
Thông tin nghiên cứu
Loại tài liệu
Bài báo trên tạp chí khoa học (Journal Article)
Tiêu đề
ứng dụng phần mềm GPA (Glaucoma Progression Analysis) trong đánh giá tiến triển bệnh glôcôm
Tác giả
Nguyễn Thị Hà Thanh; Vũ Thị Thái
Năm xuất bản
2014
Số tạp chí
10
Trang bắt đầu
16-18
ISSN
1859-1663
Abstract

Purpose: Evaluate effect of GPA software to follow-up glaucoma progression and recommend target lOP of different stage. Patients and Method: 154 eyes of 96 primary open angle glaucoma patients with treated glaucoma were prospectively enrolled and subjected to automated perimetry every 3months in 9 months. Visual acuity, intraocular pressure (lOP), retinal nerve fiber layer (RNFL) thickness was recorded. The patient had completed at least 5 visual field tests, including the 2 baseline visual field and 3 test follow-up. MD, PSD, VFi, GPA progression symbols were recorded. Glaucoma progression was identified according to Early Manifest Glaucoma Trial criterion using Glaucoma Progression Analysis software. Possible progression required at least 3 test points deteriorated p0,5 repeated in 2 visual field tests. Likely progression required at least 3 test points deteriorated p0,5 repeated in 3 visual field tests. In case unable evaluate by pattern deviation, defined progression if VFi had significant reduction with rate of progression. lOP of no- progression was recorded in different stages. Results: After 3 months, had no-progression. After 6 months, 1 eye had possible progression with 3 depressed test points. After 9 months, 3 eyes had possible progression (2 eyes had 3 depressed test points, 1 eye had 4 depressed test points). 4 eye had significant reduction of VFi. All of 7 cases lost of RNFL but less than 20pm and lOP were higher than 18mmHg in every exam. No progressive eyes had no significant difference in MD, PSD, VFi, RNFL thickness and target lOP of mild, advanced, serious, near end stages were 17.8 +/- 1.4, 16.4 +/- 1.3, 15. 1 +/- 0.8, 14.5 +/- 0.9 mmHg. Conclusions: GPA software detected glaucoma progression accurate and objective. After 9 months, progressive incidence was 4.5 percent. The lower target lOP is, the later stage is.